SLC12A2 and non-small cell lung carcinoma: Inversely, the expression of BHLHE40, C11orf86, CCDC85A, CCND3, DKK3, ETV1, HECA, ISOC1, KDM7A, LPCAT1, PAM, PEA15, PPP1R3B, PTPRE, RASGEF1B, SLC12A2, SNAP25, and WSB1 was strongly decreased in NSCLC samples compared to normal samples (Figure 7).